Niva Bupa Health Insurance (NSE:NIVABUPA, BOM:544286) has an average rating of overweight and mean price target of 92.90 Indian rupees, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Truist Securities Downgrades Sila Realty Trust to Hold From Buy, Raises Price Target to $30 From $28
Bio-Techne (TECH) has an average rating of overweight and mean price target of $65.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $70.50, Change: $+11.62, Percent Change: +19.74%
Bio-Techne (TECH) has an average rating of overweight and mean price target of $65.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)